Photodynamic Therapy: Outlook and Future Direction
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (15 October 2023) | Viewed by 9562
Special Issue Editor
2. Department of Orthopedic Dentistry, Faculty of Dentistry, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia
Interests: cell biology; photobiomodulation; tissue regeneration; bioelectromagnetism; protistology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the last 30 years, photodynamic therapy has deservedly achieved a fundamental role of recognition as a medical therapy, above all for its cytotoxic effect, thus allowing professionals to exploit a minimally invasive method capable of being very effective in various fields of medicine.
Photodynamic therapy (PDT) is a method of treating tumours, in particular cancer, the essence of which is the electoral impact on biological tissues as a result of photochemical reactions. Light energy is the catalyst of these reactions.
Photodynamic therapy (PDT) was the first drug–device combination approved by the US Food and Drug Administration (FDA) almost two decades ago, but even so, remains underutilized clinically.
PDT consists of three essential components: a photosensitizer, light, and oxygen. It is obvious that no one of these is individually toxic, but together, they initiate a photochemical reaction that culminates in the generation of a highly reactive product termed singlet oxygen and many free radicals.
Even aPDT (antimicrobial photodynamic therapy) is increasingly considered in cases of treatment of acute or chronic infections thanks to its great ability to create antimicrobial oxidative stress and consequently significantly lower the massive consumption of antibiotic molecules that cause well-known resistance by microorganisms, making treatments for this type of pathology more and more difficult.
However, both therapies are not as widely recognized as they deserve. The hope is that new research, the new combination of photosensitizers and light, and discoveries will make the knowledge of the benefits obtainable from this therapy and can also have these approaches taken into serious consideration by more professionals.
To support this Special Issue, reviews, original articles, and commentaries providing innovative interpretation and results in the field of photodynamic therapy are welcome. Authors are invited to submit manuscripts exploring aspects that point out original molecular pathways and reliable therapies. Novel approaches and state-of-the-art molecules are highly appreciated. Our Special Issue would aim to prove the molecular interactions and the contribution of PDT in therapeutic and diagnostic tools, highlighting their diverse potential and fully developing them for the future.
Dr. Andrea Amaroli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photodynamic therapy (PDT)
- photochemical reactions
- photosensitizer
- light
- oxygen
- therapeutic and diagnostic tools
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
